FibroBiologics, Inc.
FBLG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001958777
No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding FibroBiologics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 50 | 1 | 61 | +12 |
| Shares | 3.44M | 919.0K | 5.46M | +2.94M (+116.5%) |
| Value | $17.2M | $4.59M | $16.8M | +$4.22M (+33.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held FibroBiologics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,756,593 | $5.43M | 0.00% |
| Northern Trust Corp | 210,473 | $650.4K | 0.00% |
| Cerity Partners LLC | 52,100 | $161.0K | 0.00% |
| Bridgeway Capital Management, LLC | 25,000 | $77.3K | 0.00% |
| Symphony Financial, Ltd. Co. | 23,772 | $75.8K | 0.01% |
| Flaharty Asset Management, LLC | 14,702 | $45.4K | 0.01% |
| Cetera Investment Advisers | 14,166 | $43.8K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 13,916 | $43.0K | 0.00% |
| Jane Street Group, LLC | 11,852 | $36.6K | 0.00% |
| Two Sigma Investments, LP | 10,464 | $32.3K | 0.00% |
| Manufacturers Life Insurance Company, The | 10,264 | $31.7K | 0.00% |
| Voya Investment Management LLC | 10,050 | $31.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,158 | $12.8K | 0.00% |
| FMR LLC | 3,192 | $9.86K | 0.00% |
| Russell Investments Group, Ltd. | 66 | $204 | 0.00% |
| Sterling Capital Management LLC | 26 | $80 | 0.00% |
| Nisa Investment Advisors, LLC | 18 | $56 | 0.00% |
| CWM, LLC | 95 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 11 | $0 | 0.00% |
Sold out (7)
Institutions that held FibroBiologics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Transform Wealth, LLC | 133,890 | $668.1K |
| Alpine Global Management, LLC | 24,092 | $120.2K |
| Perigon Wealth Management, LLC | 16,906 | $84.4K |
| Marshall Wace, LLP | 16,702 | $83.3K |
| Mercer Global Advisors Inc | 10,272 | $51.3K |
| Envestnet Asset Management Inc | 10,272 | $51.3K |
| Northwestern Mutual Wealth Management Co | 74 | $369 |
Not filed for Q3 2024 yet (1)
Institutions that held FibroBiologics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 918,964 | $4.59M |